We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 0RKX market cap is 1.48B. The company's latest EPS is PLN -0.5508 and P/E is -52.65.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Revenue | 107.38M | 153.26M | 199.14M | 195.16M | 216.78M |
| Operating Income | 6.22M | 37.31M | -10.59M | -37.9M | -28.35M |
| Net Income | 11.94M | 21.5M | -11.61M | -39.28M | -28.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Total Assets | 591.35M | 703.64M | 707.14M | 642.76M | 569.31M |
| Total Liabilities | 146.31M | 268.97M | 153.14M | 163.12M | 123.75M |
| Total Equity | 445.04M | 434.67M | 554M | 479.65M | 445.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | PLN (PLN) | |
| Operating | -5.05M | 70.9M | 43.95M | -4.7M | -8.31M |
| Investing | -67.74M | -98.53M | -121.05M | -31.47M | -21.64M |
| Financing | -8.52M | 4.91M | 180.91M | -28.72M | -20.59M |
| Market Cap | 1.48B |
| Price to Earnings Ratio | -52.65 |
| Price to Sales Ratio | 6.83 |
| Price to Cash Ratio | 45.76 |
| Price to Book Ratio | 3.32 |
| Dividend Yield | - |
| Shares Outstanding | 51.06M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Celon Pharma Sa |
| Address |
ul. ogrodowa 2a lomianki 05-092 |
| Website | https://www.celonpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
